Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanespimycin in Metastatic Malignant Melanoma
NCT00104897Phase 2Completed
- Sponsor
- Cancer Research UK
- Start
- Mar 2005
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tanespimycin in melanoma, sponsored by Cancer Research UK. Started Mar 2005; status: completed.
02
Drugs
tanespimycin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00104897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104897.